EUVIMEDEUVIMED entdecken
Open Access

Sevoflurane Inhibits Colon Cancer Progression by Inducing Cell Autophagy and Apoptosis through the ROS/Nrf2/P62 Pathway

Xiangui Liu, Jianhua Liu, Qingbin Meng, Yongsheng Shao

Oncology Research · 2026

DOI: 10.32604/or.2026.082954 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Xiangui Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Traditional Chinese and Westemm Medicine Hospital of Wuhan, Tongji Medical College, Huazhong University of Sc…. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Reactive Oxygen Species, Colonic Neoplasms, Autophagy. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

There is debate over the effect of sevoflurane (SEV) on different cancers. This study aims to explore SEV's role in colon cancer (CC) progression.

Methods

The CC cell lines were treated with SEV at concentrations of 1.7%, 3.4%, and 5.1%. Cell proliferation, apoptosis, migration, and invasion were assessed using Cell Counting Kit-8 (CCK-8), 5-ethynyl-2'-deoxyuridine (EdU) incorporation, colony formation assay, flow cytometry, Western blot, scratch assay, and Transwell assay. A xenograft tumor model was established to evaluate the effect of SEV in vivo. Expression levels of nuclear factor erythroid 2-related factor 2 (Nrf2), p62 (sequestosome-1), microtubule-associated protein 1 light chain 3 isoform II to I ratio (LC3-II/I), Beclin-1, Bcl-2-associated X protein (Bax), and B-cell lymphoma 2 (Bcl-2) were measured. N-acetyl-L-cysteine (NAC), a ROS scavenger, was applied to determine whether ROS-dependent Nrf2/p62 signaling participated in this process.

Results

SEV inhibited CC cell proliferation, colony formation, migration, and invasion. At 5.1% SEV, cell proliferation was reduced by 54.0% (p < 0.001); colony formation decreased by 55.0% (p < 0.001); and wound closure rates dropped from 78.3% to 24.6% (p < 0.001) in HCT116 cells. Similar trends were observed in SW480 cells. Invaded cells were also significantly reduced in both cell lines (p < 0.001). SEV also induced CC apoptosis. In the xenograft model, treatment with SEV significantly suppressed tumor progression, as evidenced by reductions in both tumor volume and weight (p < 0.001). Mechanistically, SEV increased the LC3-II/I ratio and Beclin-1 expression, while decreasing Nrf2 and p62 expression both in vitro and in vivo. Moreover, NAC reversed the SEV-induced effects in vitro.

Conclusion

SEV inhibits CC progression by inducing autophagy and apoptosis via the ROS/Nrf2/p62 pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-E2-Related Factor 2Reactive Oxygen SpeciesColonic NeoplasmsAutophagySevofluraneSequestosome-1 ProteinHumansAnimalsApoptosisMiceSignal TransductionCell ProliferationXenograft Model Antitumor AssaysCell MovementCell Line, TumorDisease ProgressionRNA-Binding Proteins

Stichwörter der Autor:innen

ROS/Nrf2/p62Sevofluraneapoptosisautophagycolon cancercolorectal cancer

Substanzen

NF-E2-Related Factor 2Reactive Oxygen SpeciesNFE2L2 protein, humanSevofluraneSequestosome-1 ProteinP62 protein, humanRNA-Binding Proteins

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, Traditional Chinese and Westemm Medicine Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Thyroid and Breast Surgery, Traditional Chinese and Westemm Medicine Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Zitieren

APA

Liu, X., Liu, J., Meng, Q., & Shao, Y. (2026). Sevoflurane Inhibits Colon Cancer Progression by Inducing Cell Autophagy and Apoptosis through the ROS/Nrf2/P62 Pathway. Oncology Research. https://doi.org/10.32604/or.2026.082954

Vancouver

Liu X, Liu J, Meng Q, Shao Y. Sevoflurane Inhibits Colon Cancer Progression by Inducing Cell Autophagy and Apoptosis through the ROS/Nrf2/P62 Pathway. Oncology Research. 2026. doi:10.32604/or.2026.082954

BibTeX
@article{Liu2026,
  author = {Liu, Xiangui and Liu, Jianhua and Meng, Qingbin and Shao, Yongsheng},
  title = {Sevoflurane Inhibits Colon Cancer Progression by Inducing Cell Autophagy and Apoptosis through the ROS/Nrf2/P62 Pathway},
  journal = {Oncology Research},
  year = {2026},
  doi = {10.32604/or.2026.082954}
}
Kostenlos starten →